Results 131 to 140 of about 227,287 (224)

Two high-throughput screening assays for aberrant RNA–protein interactions in myotonic dystrophy type 1

open access: yesAnalytical and Bioanalytical Chemistry, 2012
Catherine Z. Chen   +7 more
semanticscholar   +1 more source

Analysis of high-throughput screening assays using cluster enrichment. [PDF]

open access: yesStat Med, 2012
Pu M   +7 more
europepmc   +1 more source

A general protocol for creating high-throughput screening assays for reaction yield and enantiomeric excess applied to hydrobenzoin

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2009
Shagufta H. Shabbir, C. Regan, E. Anslyn
semanticscholar   +1 more source

Fluorescence Detection-Based Functional Assay for High-Throughput Screening for MraY

open access: green, 2004
Therese‐Marie Stachyra   +8 more
openalex   +1 more source

A Homogeneous Enzyme Fragment Complementation-Based β-Arrestin Translocation Assay for High-Throughput Screening of G-Protein-Coupled Receptors [PDF]

open access: hybrid, 2008
Xiaoning Zhao   +9 more
openalex   +1 more source

Development and Implementation of a Highly Miniaturized Confocal 2D-FIDA–Based High-Throughput Screening Assay to Search for Active Site Modulators of the Human Heat Shock Protein 90β

open access: hybrid, 2004
Alain Schilb   +7 more
openalex   +1 more source

Protocol for modeling acquired resistance to targeted therapeutics in adherent and suspension cancer cell lines via in situ resistance assay

open access: yesSTAR Protocols
Summary: Acquired resistance to oncogene-targeted therapies is the major driver of mortality for patients with cancer. Here, we present a 6-to-16-week assay to model the development of acquired resistance in adherent and suspension cancer cell lines.
Nancy E. Sealover   +8 more
doaj  

Home - About - Disclaimer - Privacy